Implications of In Situ Thrombosis and Distal Embolization during Superficial Femoral Artery Endoluminal Intervention

Annals of Vascular Surgery

Volumn 24, Issue 1, 2010, Pages 14-22

  Davies, Mark G ^a   Bismuth, Jean ^a   Saad, Wael E ^a   Naoum, Joseph J ^a   Mohiuddin, Imran T ^a   Peden, Eric K ^a   Lumsden, Alan B ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL EMBOLISM; CONTROLLED STUDY; DIRECTIONAL ATHERECTOMY; EMBOLECTOMY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; IN SITU THROMBOSIS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; SUPERFICIAL FEMORAL ARTERY; THROMBOSIS;

AGED; AGED, 80 AND OVER; AMPUTATION; ANGIOPLASTY; ARTERIAL OCCLUSIVE DISEASES; ATHERECTOMY; CASE-CONTROL STUDIES; CONSTRICTION, PATHOLOGIC; DATABASES AS TOPIC; EMBOLISM; FACTOR ANALYSIS, STATISTICAL; FEMALE; FEMORAL ARTERY; HUMANS; KAPLAN-MEIERS ESTIMATE; LIMB SALVAGE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS; STENTS; THROMBOLYTIC THERAPY; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 72249096922     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.avsg.2009.06.020     Document Type: Article

References (21)

1. Davies M.G., Waldman D.L., and Pearson T.A. Comprehensive endovascular therapy for femoropopliteal arterial atherosclerotic occlusive disease. J Am Coll Surg 201 (2005) 275-296
2. Lumsden A.B., and Das T.S. Endovascular management of infrainguinal disease. J Endovasc Ther 13 Suppl. 2 (2006) II1-II2
3. TASC Working Group. Management of peripheral arterial disease (PAD): Transatlantic Inter-Society Consensus (TASC). Eur J Vasc Endovasc Surg 19 (2000) S1-S244
4. TASC II Working Group. TASC-II: Inter-Society Consensus for the management of peripheral vascular arterial disease. J Vasc Surg 45 Suppl. S (2007) S1-S67
5. DeRubertis B.G., Vouyouka A., Rhee S.J., et al. Percutaneous intervention for infrainguinal occlusive disease in women: equivalent outcomes despite increased severity of disease compared with men. J Vasc Surg 38 (2008) 150-158
6. Bakken A.M., Palchik E., Hart J.P., Rhodes J.M., Saad W.E., and Davies M.G. Impact of diabetes on the outcomes of superficial femoral artery endoluminal interventions. J Vasc Surg 46 (2007) 946-958
7. Bakken A.M., Protack C.D., Saad W.E.A., et al. Impact of chronic kidney disease on outcomes of superficial femoral artery endoluminal interventions. Ann Vasc Surg (2009) (in press)
8. Davies M.G., Saad W.E., Peden E.K., Mohiuddin I.T., Naoum J.J., and Lumsden A.B. Impact of runoff on superficial femoral artery endoluminal interventions for rest pain and tissue loss. J Vasc Surg 48 (2008) 619-626
9. Davies M.G., Saad W.E., Peden E.K., Mohiuddin I.T., Naoum J.J., and Lumsden A.L. Percutaneous superficial femoral artery interventions for claudication-does runoff matter?. Ann Vasc Surg 22 (2008) 790-798
10. Galaria I.I., Surowiec S.M., Rhodes J.M., Illig K.A., Shortell C.K., and Davies M.G. Implications of early failure of superficial femoral artery endoluminal interventions. Ann Vasc Surg 19 (2005) 787-792
11. Ryer E.J., Trocciola S.M., DeRubertis B., et al. Analysis of outcomes following failed endovascular treatment of chronic limb ischemia. Ann Vasc Surg 20 (2006) 440-446
12. Al-Hamali S., Baskerville P., Fraser S., Walters H., and Markus H.S. Detection of distal emboli in patients with peripheral arterial stenosis before and after iliac angioplasty: a prospective study. J Vasc Surg 29 (1999) 345-351
13. Shammas N.W., Dippel E.J., Coiner D., Shammas G.A., Jerin M., and Kumar A. Preventing lower extremity distal embolization using embolic filter protection: results of the PROTECT registry. J Endovasc Ther 15 (2008) 270-276
14. Lam R.C., Shah S., Faries P.L., McKinsey J.F., Kent K.C., and Morrissey N.J. Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery. J Vasc Surg 46 (2007) 1155-1159
15. Suri R., Wholey M.H., Postoak D., Hagino R.T., and Toursarkissian B. Distal embolic protection during femoropopliteal atherectomy. Catheter Cardiovasc Interv 67 (2006) 417-422
16. Karnabatidis D., Katsanos K., Kagadis G.C., et al. Distal embolism during percutaneous revascularization of infra-aortic arterial occlusive disease: an underestimated phenomenon. J Endovasc Ther 13 (2006) 269-280
17. Grundy S.M., Brewer H.B.J., and Cleeman J.I. for the Conference Participants. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
18. Rutherford R.B., Baker J.D., Ernst C., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997) 517-538
19. Jorgensen B., Meisner S., Holstein P., and Tonnesen K.H. Early rethrombosis in femoropopliteal occlusions treated with PTA. Eur J Vasc Surg 4 (1990) 149-152
20. Cutlip D.E. Stent thrombosis: historical perspectives and current trends. J Thromb Thrombolysis 10 (2008) 89-101
21. Golino P., and Chiariello M. New approaches to the prevention of thrombotic restenosis after angioplasty or thrombolysis. J Cardiovasc Pharmacol 17 Suppl. 5 (1991) S41-S47